S-ICD System
Sponsors
Boston Scientific Corporation
Conditions
Primary Prevention of Sudden Cardiac ArrestSecondary Prevention of Sudden Cardiac ArrestTachycardia, Ventricular
Unknown Phase
S-ICD® System IDE Clinical Study
CompletedNCT01064076
Start: 2010-01-31End: 2013-01-31Updated: 2017-03-27
Boston Scientific Post Market Subcutaneous-Implantable Cardioverter Defibrillator (S-ICD) Registry
CompletedNCT01085435
Start: 2011-02-02End: 2024-01-31Updated: 2025-05-20
S-ICD® System Post Approval Study
CompletedNCT01736618
Start: 2013-03-12End: 2021-10-15Updated: 2024-03-18